| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.2M | — | — |
| R&D Expense | $177.5M | — | +32.2% |
| SG&A Expense | $61.6M | — | +112.3% |
| Operating Income | -$233.6M | — | -43.1% |
| Pre-tax Income | -$109.8M | — | -33.3% |
| Income Tax | $168K | — | +320.0% |
| Net Income | -$110.0M | — | -33.4% |
| EPS (Basic) | -$0.12 | — | -9.1% |
| EPS (Diluted) | -$0.12 | — | -9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $874.5M | +263.2% | +615.1% |
| Short-term Investments | $1.59B | +36.4% | +130.6% |
| Accounts Receivable | $11.5M | +61.1% | — |
| Current Assets | $2.51B | +73.7% | +198.5% |
| Total Assets | $2.93B | +63.1% | +170.1% |
| Current Liabilities | $113.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$144.4M | — | -30.2% |
| Capital Expenditures | $77.9M | — | +421.1% |
| Investing Cash Flow | -$505.5M | — | -1700.1% |
| Financing Cash Flow | $1.28B | — | — |
| Free Cash Flow | -$222.4M | — | -76.6% |
| +139.8% |
| Long-term Debt | $701.1M | — | — |
| Total Liabilities | $969.9M | +151.7% | +331.9% |
| Stockholders' Equity | $1.96B | +38.9% | +127.8% |